Advanced Research on Non-small Cell Lung Cancer with De Novo T790M Mutation
With the development of sequencing technology, the detection rate of de novo T790M mutation is increasing. The emergence of the third generation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) provide treatment opportunities. Secondary T790M mutation is often emphasized...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Chinês |
| Baskı/Yayın Bilgisi: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-05-01
|
| Seri Bilgileri: | Chinese Journal of Lung Cancer |
| Konular: | |
| Online Erişim: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.05.10 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|